review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1002/DMRR.551 |
P698 | PubMed publication ID | 15818714 |
P2093 | author name string | Fedele D | |
Lapolla A | |||
Dalfrà MG | |||
P2860 | cites work | Excursion of daily glucose profiles in pregnant women with IDDM: relationship with perinatal outcome | Q74291359 |
Preconception care of women with diabetes | Q75205692 | ||
Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes | Q77761936 | ||
Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy | Q77762038 | ||
Immune responses to insulin aspart and biphasic insulin aspart in people with type 1 and type 2 diabetes | Q78014804 | ||
Preliminary experience with the use of insulin lispro in pregnant diabetic women | Q78773415 | ||
Transcriptional regulation of adipocyte hormone-sensitive lipase by glucose | Q28216725 | ||
Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog). | Q30879494 | ||
Insulin analogues and their potential in the management of diabetes mellitus | Q33753661 | ||
Why do diabetic women deliver malformed infants? | Q33850109 | ||
Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis | Q34086183 | ||
Association between outcome of pregnancy and glycaemic control in early pregnancy in type 1 diabetes: population based study | Q34360780 | ||
Insulins today and beyond | Q34365284 | ||
Intermediate metabolism in normal pregnancy and in gestational diabetes. | Q35184288 | ||
Insulin lispro therapy in pregnancies complicated by type 1 diabetes: glycemic control and maternal and fetal outcomes | Q35198990 | ||
Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study | Q36245629 | ||
Banting Lecture 1980. Of pregnancy and progeny | Q40294865 | ||
Type I diabetes mellitus and pregnancy | Q40439867 | ||
Transplacental passage of insulin in pregnant women with insulin-dependent diabetes mellitus. Its role in fetal macrosomia | Q41204557 | ||
Retinopathy risk: what is responsible? Hormones, hyperglycemia, or humalog? Response to Kitzmiller et al. | Q41665884 | ||
Metabolic and immunologic effects of insulin lispro in gestational diabetes | Q41689564 | ||
Third-trimester maternal glucose levels from diurnal profiles in nondiabetic pregnancies: correlation with sonographic parameters of fetal growth | Q43687889 | ||
Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus | Q44126489 | ||
Comparison of an insulin analog, insulin aspart, and regular human insulin with no insulin in gestational diabetes mellitus | Q44262770 | ||
Progression of retinopathy during pregnancy in type 1 diabetic women treated with insulin lispro | Q44381386 | ||
Transfer of insulin lispro across the human placenta: in vitro perfusion studies | Q44418797 | ||
Two consecutive pregnancies in a type 1 diabetic under treatment with insulin Lispro | Q44423251 | ||
Maternal metabolic control and perinatal outcome in women with gestational diabetes treated with regular or lispro insulin: comparison with non-diabetic pregnant women | Q44616167 | ||
Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy | Q45081402 | ||
Maternal postprandial glucose levels and infant birth weight: the Diabetes in Early Pregnancy Study. The National Institute of Child Health and Human Development--Diabetes in Early Pregnancy Study | Q46287029 | ||
Weight and length at birth of infants of diabetic mothers | Q47442686 | ||
St Vincent's Declaration 10 years on: outcomes of diabetic pregnancies | Q47615037 | ||
Effects of a monounsaturated fatty acid-enriched hypocaloric diet on cardiovascular risk factors in obese patients with type 2 diabetes. | Q51570864 | ||
Pregnancy outcomes in the Diabetes Control and Complications Trial | Q71064327 | ||
Is insulin lispro associated with the development or progression of diabetic retinopathy during pregnancy? | Q73205604 | ||
Glycaemic control during early pregnancy and fetal malformations in women with type I diabetes mellitus | Q73420349 | ||
Possible adverse fetal effect of insulin lispro | Q73737286 | ||
Elevated serum thyrotropin in thyroxine-treated patients with hypothyroidism given sertraline | Q73737290 | ||
Insulin lispro and regular insulin in pregnancy | Q73881814 | ||
Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use | Q73922459 | ||
Use of insulin glargine during pregnancy in a type 1 diabetic woman | Q74181563 | ||
Evaluation of the reproductive toxicity and embryotoxicity of insulin glargine (LANTUS) in rats and rabbits | Q74260762 | ||
P433 | issue | 3 | |
P921 | main subject | gestational diabetes | Q126691 |
Insulin Therapy | Q2002370 | ||
preproinsulin | Q7240673 | ||
P304 | page(s) | 241-252 | |
P577 | publication date | 2005-05-01 | |
P1433 | published in | Diabetes - Metabolism: Research and Reviews | Q15750056 |
P1476 | title | Insulin therapy in pregnancy complicated by diabetes: are insulin analogs a new tool? | |
P478 | volume | 21 |
Q48634385 | Altered expression and localization of synaptophysin in developing cerebellar cortex of neonatal rats due to maternal diabetes mellitus. |
Q90011751 | Comparative effects of glibenclamide, metformin and insulin on fetal pancreatic histology and maternal blood glucose in pregnant streptozotocin-induced diabetic rats |
Q51305704 | Diabetic pregnancy outcomes in mothers treated with basal insulin lispro protamine suspension or NPH insulin: a multicenter retrospective Italian study. |
Q50554734 | Effects of streptozotocin-induced type 1 maternal diabetes on PI3K/AKT signaling pathway in the hippocampus of rat neonates. |
Q47893218 | Expression of apoptosis-regulatory genes in the hippocampus of rat neonates born to mothers with diabetes. |
Q35604253 | Gestational diabetes mellitus: challenges in diagnosis and management |
Q27026752 | Insulin analogues in the treatment of diabetes in pregnancy |
Q37346167 | Insulin aspart in diabetic pregnancy: state of the art. |
Q37144833 | Insulin treatment in diabetic pregnancy |
Q40435258 | Insulin-Like Growth Factor-1 Receptor Is Differentially Distributed in Developing Cerebellar Cortex of Rats Born to Diabetic Mothers |
Q34620699 | Management of gestational diabetes mellitus |
Q37314744 | Peripartum management of diabetes |
Q35437761 | Some of the experimental and clinical aspects of the effects of the maternal diabetes on developing hippocampus |
Q40026648 | Stereological study of the effects of maternal diabetes on cerebellar cortex development in rat. |
Q28571907 | The effects of induced type-I diabetes on developmental regulation of insulin & insulin like growth factor-1 (IGF-1) receptors in the cerebellum of rat neonates |
Q44967481 | The effects of maternal diabetes on expression of insulin-like growth factor-1 and insulin receptors in male developing rat hippocampus. |
Q79394612 | The insulin analog glargine during an unplanned pregnancy |
Q57688911 | Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews |
Q26779412 | Use of Insulin Lispro Protamine Suspension in Pregnancy |
Search more.